This site requires JavaScript and cookies to be enabled.

Chloe Kim’s ADHD story

Chloe pushes boundaries on the mountain. But off the slopes, ADHD is a different challenge. After years of masking her symptoms, Chloe spoke with her doctor and found a treatment plan that includes once-a-day Qelbree to help manage her ADHD symptoms.

Chloe Kim is a real Qelbree patient and paid spokesperson.

Behind the medals, Chloe faced challenges she struggled to understand

Chloe Kim's Story: ADHD Beyond the Gold

Chloe’s ADHD diagnosis in her 20s gave a name to what she’d been experiencing—and a new understanding of herself.

From the outside, Chloe Kim looked like she had everything figured out—excelling on the halfpipe while struggling with everyday tasks behind the scenes. After years of telling herself to “just try harder,” an honest conversation with her doctor led to an ADHD diagnosis in her 20s.

Finding once-a-day, non-stimulant Qelbree gave Chloe a treatment option that fits into her routine and helps her manage her ADHD symptoms. Now, she’s sharing her story to help challenge the stigma around asking for help and encourage others to talk to their doctor about ADHD.

Owning Her Patterns: Chloe Kim’s Journey to Ms. Represented

By sharing the patterns that led to her diagnosis, Chloe is opening up the conversation for other women living with ADHD.

Missed texts. Forgotten appointments. For a long time, Chloe Kim thought these everyday struggles were just personal shortcomings—not how ADHD often presents in women.

After a diagnosis and a conversation with her doctor, Chloe was prescribed Qelbree, a non-stimulant medication that helps her manage her ADHD symptoms. Watch her story and learn how recognizing the patterns can help women advocate for their own care.

Challenging perceptions of ADHD in women

ADHD in women can be overlooked or misunderstood, making it harder to recognize the signs and seek support. By sharing her journey, Chloe hopes to empower women—no matter what stage of life they’re in—to advocate for their health and talk to a doctor about potential ADHD symptoms.
If I could tell younger me one thing, it's that asking for help with my ADHD isn't a weakness. It was literally the first step to understanding myself.”
Chloe Kim

Professional snowboarder with ADHD
Paid spokesperson for Qelbree

See more ADHD stories

See the difference Qelbree is making in helping real people manage their ADHD.
Explore stories

Share your story

Share your experience of navigating ADHD with Qelbree.
Share your story

ADHD and gender

Did you know that ADHD can look different in women and men?
Explore the differences

Connect with the Qelbree community

Follow Qelbree on social media for updates.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.